Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Cancer - National Press Club to Host 'NEWSMAKER' Media Briefing on Health Policy Recommendations With Dr. John Mendelsohn
Coagulation - ATryn® (Antithrombin [Recombinant]) Approved by the FDA
Cubist Pharmaceuticals, Inc. - Cubist Plans to Commence Patent Infringement Litigation against Teva Parenteral Medicines, Inc. In Response To ANDA filing
Guided Therapeutics, Inc. - Guided Therapeutics, Inc. Reports Preliminary Findings from FDA Pivotal Clinical Trial
Absorption Systems - FDA Awards Absorption Systems Phase I SBIR Grant for CellPort Technologies™
Aeolus Pharmaceuticals, Inc. - NIH CounterACT Program Begins Studies of Aeolus Pharmaceuticals’ AEOL 10150 as a Countermeasure to Sulfur Mustard Gas Exposure
Brainstorm Cell Therapeutics Inc. - BrainStorm Cell Therapeutics’ Consultant to Assist with Final Regulatory Preparations Towards Clinical Trials for ALS Patients Based on Stem Cells Treatment
Breast Cancer Screening - Reports summarize breast cancer screening research from R.K.F. Hogben and co-authors
Breast Implants - Research from Georgetown University in the area of breast implants published
Cancer - FDA approves clinical studies of a novel anti-cancer drug developed by the Italian research; Nerviano Medical Sciences (NMS)gets green light from the FDA
Cancer Vaccines - ImQuest Presents IND-Enabling Safety Pharmacology and Pharmacokinetic Data for the Therapeutic HIV Compound IQP-0410 at Conference on Retroviruses and Opportunistic Infections
Cervical Cancer - New Local TV Ad Campaign To Educate Memphis Women About Cervical Cancer Prevention and HPV Testing
Cervical Cancer - New Local TV Ad Campaign To Educate St. Louis Women About Cervical Cancer Prevention and HPV Testing
Chemical Warfare - Findings from L. Rozsa and co-authors provide new insights into chemical warfare
Cholestasis - New cholestasis study results from University of Tokyo described
Cougar Biotechnology, Inc. - Cougar Biotechnology Announces Agreement with FDA on Special Protocol Assessment for Phase III Trial of CB7630 Abiraterone Acetate in Chemotherapy Naive Castration Resistant Prostate Cancer Patients
Defense Logistics Agency - FEMA/Defense Logistics Agency Order 660,000 Military Meals Ready to Eat MREs for Immediate Shipment to Kentucky and Arkansas Storm Victims; All Military MREs are Safe to Eat and are not Affected by the Peanut Butter Rec
Dengue Fever - Studies from Purdue University update current data on dengue fever
Diabetes - Highly Anticipated No-Code WaveSense Jazz Glucose Meter Available Exclusively at Diabetic Care Services and Diabetic Express
Drug Resistance - Findings in drug resistance reported from University of Maryland
Dynavax Technologies Corporation - Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAVTM Hepatitis B Vaccine
Echocardiography - New echocardiography data have been reported by M.L. Main and co-authors
Emergent BioSolutions Inc. - Emergent BioSolutions Announces That BioThrax Anthrax Vaccine Adsorbed Receives Market Authorization in India
Escherichia Coli - New Escherichia coli research from T. de Sablet and colleagues discussed
Escherichia Coli - New Escherichia coli study findings recently were reported by M.B. Jenkins and co-researchers
Escherichia Coli - Studies from Department of Agriculture yield new information about Escherichia coli
Flavivirus - Research conducted at Iowa State University, Medical Department has provided new information about flavivirus
Gallstone Disease - Research from Princess Royal University in the area of gallstone disease described
General Mills - General Mills Announces Commitment to Make Yoplait® Yogurt Products 100 Percent Free of Milk from Cows Treated With rBST by August 2009
Genta Incorporated - Genta Submits Randomized Study of Tesetaxel in Patients with Advanced Gastric Cancer to FDA for Special Protocol Assessment
Graft-Versus-Host Disease - DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
Guillain-Barre Syndrome Vaccines - Report summarizes Guillain-Barre syndrome vaccines study findings from Health Protection Agency Center for Infections
Heart Disease - World's First Cardiac Adult Stem Cell Trial to Take Place in Louisville
Hematology - Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
Hepatocellular Cancer - Studies from N. Muszbek and co-authors have provided new information about hepatocellular cancer
HIV/AIDS - PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
Immunization - Studies from J.J. Mcsharry and colleagues reveal new findings on immunization
Natural Products Association - Evidence Lacking in Multivitamin Study of Women's Risk of Cancer, Heart Disease or Death, Says Natural Products Association
NeoPharm, Inc. - NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Castrate Resistant Prostate Cancer
Non-Hodgkin Lymphoma - Cell Therapeutics and Idis Announce Agreement for a European Named Patient/compassionate Use Program for Pixantrone
Non-Hodgkin Lymphoma - Reports on non-hodgkin lymphoma findings from Aarhus University provide new insights
Oncology - Australia's Leading Oncology Drug Compounder Chooses RIVA System
Plague - Researchers from University of Michigan report recent findings in plague
Progenics Pharmaceuticals, Inc. - Progenics Selects Subcutaneous Form of PRO 140, a Novel HIV Antibody Therapy, for Further Development
Prostate Cancer - Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
Proteomics - New proteomics data have been reported by researchers at National Institute of Health and Family Welfare
pSivida Corp. - pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2008; Iluvien™ NDA filing remains on schedule for early calendar 2010; Final two-year patient visit scheduled for October 2009
Regulatory Actions - New regulatory actions findings from Charles University described
Reproductive Health - Researchers from University of Glamorgan detail new studies and findings in the area of reproductive health
Research - Molecules help the immune system to detect cells infected with West Nile virus
Thrombocytopenic Purpura - Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Thrombolysis - New thrombolysis study results reported from Karolinska University
Tissue Engineering - Studies from Erasmus University add new findings in the area of tissue engineering
VasoGenix Pharmaceuticals Inc. - VasoGenix Pharmaceuticals Selects a Lead CGRP Calcitonin Gene-Related Peptide Agonist Analog to Develop as a Heart Failure
Virgin Trains - Photocall: Roman Centurions at Euston Station, 16 February